The Scientist

» iPSCs, ecology and disease/medicine

Most Recent

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Little Fish in a Big Pond

Little Fish in a Big Pond

By | November 1, 2012

Continued overfishing of forage fish such as sardines and herring can result in devastating ecological and economic outcomes.

1 Comment

image: Microbial Awakening

Microbial Awakening

By | November 1, 2012

Successive awakening of soil microbes drives a huge pulse of CO2 following the first rain after a dry summer.

1 Comment

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Birthday Conference

The Birthday Conference

By | November 1, 2012

Snapshots from an annual meeting that celebrates the birth of a prominent biologist

0 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: A Celebrated Symposium

A Celebrated Symposium

By | November 1, 2012

A conference, started 10 years ago partly as a disease ecologist’s birthday party, has become one of the most valued meetings in the field.  

0 Comments

image: Long and Rocky Roads

Long and Rocky Roads

By | November 1, 2012

From basic research to beneficial therapies

0 Comments

image: Metabolomics Sheds Light on TB Drug

Metabolomics Sheds Light on TB Drug

By | November 1, 2012

Understanding the mechanism of a classic tuberculosis treatment could refine future strategies for TB drug development.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech